Active Substance & Generic Molecule Directory
Chicken Comb Extract in Malaysia: Registered Brands, Dosages & Price Comparison
Directory of all approved pharmaceutical brands containing Chicken Comb Extract registered with the National Pharmaceutical Regulatory Agency (NPRA) / Ministry of Health Malaysia (KKM).
10
Registered Brands
Availability in Malaysia:10 Supplements (MAL-N)
Showing 10 of 10 registered brands
| MAL Reg No | Brand Formulation Name | Strength / Dosage | Classification | Registration Holder | Action |
|---|---|---|---|---|---|
| MAL16075041NC | CollaH Capsule | 85mg 450mg | Health Supplement (MAL-N) | MB NUTRACEUTICALS SDN BHD | Compare → |
| MAL25116101NC | DERMNEE Capsule | 80 mg 520 mg | Health Supplement (MAL-N) | MB NUTRACEUTICALS SDN BHD | Compare → |
| MAL24086143NC | FLEXINEE CAPSULE | 40 mg 230 mg | Health Supplement (MAL-N) | MB NUTRACEUTICALS SDN BHD | Compare → |
| MAL20172832N | HYALUFLEX HA CAPSULE | 40mg 400mg | Health Supplement (MAL-N) | WINWA MEDICAL SDN. BHD. | Compare → |
| MAL17086017N | Hyaluflex HA PRO Powder (Lemon Lime Flavour) | 80 mg 2 g | Health Supplement (MAL-N) | WINWA MEDICAL SDN. BHD. | Compare → |
| MAL18016117NC | Kordel's M-JFlexi Powder | 0.08 g 10 g | Health Supplement (MAL-N) | CAMBERT(M) SDN. BHD. | Compare → |
| MAL16025020NC | MOBAL capsule | 40mg 280mg | Health Supplement (MAL-N) | MB NUTRACEUTICALS SDN BHD | Compare → |
| MAL20106050NC | Mobithron Advance Capsule | 80.00 mg 450.00 mg | Health Supplement (MAL-N) | BREGO LIFE SCIENCES SDN. BHD | Compare → |
| MAL24116073NC | Mobithron Complete Capsule | 80.0 mg 670 mg | Health Supplement (MAL-N) | BREGO LIFE SCIENCES SDN. BHD | Compare → |
| MAL18086010NC | Mobithron P Capsule | 80.00 mg 500.00 mg | Health Supplement (MAL-N) | BREGO LIFE SCIENCES SDN. BHD | Compare → |
Generic Bioequivalence & Drug Substitution in Malaysia
Generic medications registered under NPRA contain the identical active pharmaceutical ingredient (API) in identical dosage strength and route of administration as the originator brand. NPRA requires rigorous bioequivalence (BE) studies demonstrating that generic drugs deliver the exact therapeutic effect. Always confirm with your doctor or community pharmacist before switching between prescription brands.